BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.
BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 204 53" xmlns="http://www.w3.org/2000/svg"><g d="M 181 48.5 C 171.43 48.5 167 41.42 167 27.67 C 167 13.92 171.72 6.5 181.47 6.5 C 189.06 6.5 193.23 10.7 194.22 19.66 L 187.62 20.61 C 187.23 15.29 185.07 13.13 181.36 13.13 C 175.16 13.13 173.72 19.15 173.72 27.21 C 173.72 37.63 176.12 41.85 181.25 41.85 C 185.06 41.85 187.31 39.53 187.8 33.56 L 194.38 34.43 C 193.41 43.78 188.8 48.49 181 48.49 Z M 152.67 48.5 C 145.31 48.5 140.21 44.08 139.76 35 L 146.41 34.19 C 146.7 39.9 148.99 42.23 152.73 42.23 C 155.89 42.23 157.85 40.55 157.85 37.33 C 157.85 32.93 154.3 31.59 150.39 30.16 C 145.49 28.37 139.93 26.35 139.93 18.04 C 139.93 10.26 144.78 6.5 152 6.5 C 159.22 6.5 163.68 10.5 164.18 19.1 L 157.56 19.88 C 157.33 14.81 155.5 12.77 151.79 12.77 C 148.71 12.77 146.65 14.23 146.65 17.53 C 146.65 21.84 150.11 23.13 153.66 24.42 C 159.14 26.41 164.51 28.31 164.51 36.54 C 164.51 44.13 159.97 48.5 152.67 48.5 Z M 112 47.58 L 112 7.43 L 125.37 7.43 C 131.89 7.43 135.25 11.07 135.25 17.45 C 135.25 21.57 133.87 24.81 130.87 26.44 C 134.29 27.7 135.88 30.98 135.88 35.74 C 135.88 42.96 132.23 47.58 125.87 47.58 Z M 118.61 40.94 L 124.79 40.94 C 127.56 40.94 129.17 38.98 129.17 35.12 C 129.17 31.54 127.68 29.41 124.87 29.41 L 118.61 29.41 L 118.61 40.95 Z M 118.61 24 L 124.45 24 C 127.09 24 128.57 21.98 128.57 18.74 C 128.57 15.16 126.74 14.06 124.55 14.06 L 118.61 14.06 Z M 87.94 45.73 L 96.61 45.73 C 77.59 45.73 75.05 9.5 60.99 9.5 C 46.93 9.5 44.49 45.73 23.33 45.73 L 0 45.73 M 1 45.64 C 33.95 45.64 27.81 0.5 44.18 0.5 C 60.55 0.5 56.76 45.64 88.07 45.64 M 190.5 4.5 C 190.5 2.015 192.515 0 195 0 C 197.485 0 199.5 2.015 199.5 4.5 C 199.5 6.985 197.485 9 195 9 C 192.515 9 190.5 6.985 190.5 4.5 Z M 193.2 1.9 L 193.2 7.1 L 194 7.1 L 194 4.9 L 195 4.9 L 196.2 7.1 L 197.1 7.1 L 195.8 4.8 C 196.5 4.5 196.9 4 196.9 3.2 C 196.9 2.4 196.3 1.9 195.3 1.9 Z M 194 2.6 L 195.2 2.6 C 195.9 2.6 196.2 2.9 196.2 3.3 C 196.2 3.8 195.9 4.1 195.2 4.1 L 194 4.1 Z" fill="transparent" height="48.5px" id="ywWlup494" transform="translate(0 4)" width="199.5px"><path d="M 69 42 C 59.43 42 55 34.92 55 21.17 C 55 7.42 59.72 0 69.47 0 C 77.06 0 81.23 4.2 82.22 13.16 L 75.62 14.11 C 75.23 8.79 73.07 6.63 69.36 6.63 C 63.16 6.63 61.72 12.65 61.72 20.71 C 61.72 31.13 64.12 35.35 69.25 35.35 C 73.06 35.35 75.31 33.03 75.8 27.06 L 82.38 27.93 C 81.41 37.28 76.8 41.99 69 41.99 Z M 40.67 42 C 33.31 42 28.21 37.58 27.76 28.5 L 34.41 27.69 C 34.7 33.4 36.99 35.73 40.73 35.73 C 43.89 35.73 45.85 34.05 45.85 30.83 C 45.85 26.43 42.3 25.09 38.39 23.66 C 33.49 21.87 27.93 19.85 27.93 11.54 C 27.93 3.76 32.78 0 40 0 C 47.22 0 51.68 4 52.18 12.6 L 45.56 13.38 C 45.33 8.31 43.5 6.27 39.79 6.27 C 36.71 6.27 34.65 7.73 34.65 11.03 C 34.65 15.34 38.11 16.63 41.66 17.92 C 47.14 19.91 52.51 21.81 52.51 30.04 C 52.51 37.63 47.97 42 40.67 42 Z M 0 41.08 L 0 0.93 L 13.37 0.93 C 19.89 0.93 23.25 4.57 23.25 10.95 C 23.25 15.07 21.87 18.31 18.87 19.94 C 22.29 21.2 23.88 24.48 23.88 29.24 C 23.88 36.46 20.23 41.08 13.87 41.08 Z M 6.61 34.44 L 12.79 34.44 C 15.56 34.44 17.17 32.48 17.17 28.62 C 17.17 25.04 15.68 22.91 12.87 22.91 L 6.61 22.91 L 6.61 34.45 Z M 6.61 17.5 L 12.45 17.5 C 15.09 17.5 16.57 15.48 16.57 12.24 C 16.57 8.66 14.74 7.56 12.55 7.56 L 6.61 7.56 Z" fill="rgb(36, 105, 176)" height="42px" id="bH2CKyS1R" transform="translate(112 6.5)" width="82.38000000000005px"/><path d="M 87.94 36.23 L 96.61 36.23 C 77.59 36.23 75.05 0 60.99 0 C 46.93 0 44.49 36.23 23.33 36.23 L 0 36.23" fill="transparent" height="36.22999999999999px" id="hswDYHlbc" stroke-dasharray="" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="3.86" stroke="rgb(36, 105, 176)" transform="translate(0 9.5)" width="96.6099999999999px"/><path d="M 0 45.14 C 32.95 45.14 26.81 0 43.18 0 C 59.55 0 55.76 45.14 87.07 45.14" fill="transparent" height="45.14px" id="X3dpqbPdb" stroke-dasharray="" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="3.86" stroke="rgb(36, 105, 176)" transform="translate(1 0.5)" width="87.06999999999994px"/><g d="M 0 4.5 C 0 2.015 2.015 0 4.5 0 C 6.985 0 9 2.015 9 4.5 C 9 6.985 6.985 9 4.5 9 C 2.015 9 0 6.985 0 4.5 Z M 2.7 1.9 L 2.7 7.1 L 3.5 7.1 L 3.5 4.9 L 4.5 4.9 L 5.7 7.1 L 6.6 7.1 L 5.3 4.8 C 6 4.5 6.4 4 6.4 3.2 C 6.4 2.4 5.8 1.9 4.8 1.9 Z M 3.5 2.6 L 4.7 2.6 C 5.4 2.6 5.7 2.9 5.7 3.3 C 5.7 3.8 5.4 4.1 4.7 4.1 L 3.5 4.1 Z" fill="transparent" height="9px" id="YQXS_7R5x" transform="translate(190.5 0)" width="9px"><path d="M 0 4.5 C 0 2.015 2.015 0 4.5 0 C 6.985 0 9 2.015 9 4.5 C 9 6.985 6.985 9 4.5 9 C 2.015 9 0 6.985 0 4.5 Z" fill="transparent" height="9px" id="gP104MhUu" stroke-dasharray="" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="0.7" stroke="rgb(36, 105, 176)" width="9px"/><path d="M 0 0 L 0 5.2 L 0.8 5.2 L 0.8 3 L 1.8 3 L 3 5.2 L 3.9 5.2 L 2.6 2.9 C 3.3 2.6 3.7 2.1 3.7 1.3 C 3.7 0.5 3.1 0 2.1 0 Z M 0.8 0.7 L 2 0.7 C 2.7 0.7 3 1 3 1.4 C 3 1.9 2.7 2.2 2 2.2 L 0.8 2.2 Z" fill="rgb(36, 105, 176)" height="5.200000000000002px" id="rAdmRJTiF" transform="translate(2.7 1.9)" width="3.9000000000000057px"/></g></g></svg>)
All
Knowledge Base
News
Therapy Areas
Glossary
FAQ
Guidance Docs
21 CFR Part 11
510(k)
510(k) Clearance
ADaM (Analysis Data Model)
Adaptive Design
Adaptive Enrichment Design
Adverse Event
Advisory Committee (Panel Meeting)
Alpha-Spending Function
Annotated CRF
Approvable Letter
Audit Trail
Bayesian Methods
Benefit-Risk Assessment
Blinded Assessment
Blinding/Masking
Breakthrough Device Designation
CE Marking
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center for Drug Evaluation and Research (CDER)
Clinical Data Interchange Standards Consortium
Clinical Events Committee
Clinical Study Report
Co-Primary Endpoints
Competing Risks Analysis
Complete Response Letter
Composite Endpoint
Conditional Power
Confidence Interval
Core Lab
Core Lab Assessment
Crossover Design
Data Safety Monitoring Board/Data Monitoring Committee
Data Specifications
Database Lock
De Novo
Define.xml
Device Deficiency
Early Treatment Diabetic Retinopathy Study
Effect Size
Efficacy Endpoints
Electronic Case Report Form
Electronic Common Technical Document
Electronic Data Capture
Enrollment/Accrual
Equivalence Design
European Medicines Agency
Exploratory Endpoint
FDA Guidance Document
FDA Pre-Submission
Feasibility Study
First-in-Human Study
Follow-up
Frequentist Methods
Full Analysis Set
Futility Analysis
Good Clinical Practice
Good Laboratory Practice
Good Manufacturing Practice
Health Canada
Hierarchical (Mixed-Effects) Model
Historical Controls
Humanitarian Device Exemption
ICH E3
ICH E6
ICH E9
ICH E9(R1)
Informative Prior
Informed Consent Form
Institutional Review Board/Ethics Committee
Integrated Summary of Effectiveness
Integrated Summary of Safety
Intent-to-Treat Analysis Set
Intercurrent Event
Interim Analysis
International Council for Harmonisation
Investigational Device Exemption
Investigator's Brochure
Last Observation Carried Forward
Lost to Follow-up
Major Adverse Cardiac Events
Medical Dictionary for Regulatory Activities
Meta-Analysis
Methodological Innovation
Minimum Clinically Important Difference
Missing at Random
Missing Completely at Random (MCAR)
Missing Data
Missing Not at Random
Modified Intent-to-Treat Analysis Set
Multiple Imputation
National Health Commission of the People’s Republic of China
National Medical Products Administration
Neck Disability Index
Non-Inferiority Design
Non-Informative (Vague) Prior
Notified Body
Null Hypothesis
Observer-Reported Outcomes (ObsROs)
Oswestry Disability Index
p-value
Panel Preparation
Parallel Design
Patient-Reported Outcomes
Pattern-Mixture Models
Per-Protocol Analysis Set
Performance Goal (Objective Performance Criterion)
Performance Outcomes
Pharmaceuticals and Medical Devices Agency
Pivotal Trial
Platform Trial
Post-Market Study
Posterior Probability of Success
Pre-Sub Package
Preferred Term
Premarket Approval
Primary Endpoint
Principal Stratification
Propensity Score Methods
Protocol
Protocol Amendment
Protocol Deviation
Radiographic Success
Random Effects
Randomized Controlled Trial
Registry Trial
Regulatory Biostatistics
Rescue Therapy
Response Evaluation Criteria in Solid Tumors
Response-Adaptive Randomization
Safety Endpoints
Sample Size
Sample Size Re-estimation
SAS
Seamless Phase II/III Design
Secondary Endpoint
Sensitivity Analysis
Serious Adverse Event
SF-36
Sham Control
Single-Arm Study
Standard Operating Procedures
Statistical Analysis Plan
Statistical Power
Steering Committee
Stopping Rules
Study Data Tabulation Model
Submission-Grade Analysis
Summary of Safety and Effectiveness Data
Superiority Design
Surrogate Endpoint
Synthetic Control Arm
System Organ Class
Tables, Listings, and Figures
Time-in-Range
Tipping Point Analysis
Type A Meeting
Type B Meeting
Type C Meeting
Type I Error (Alpha)
Type II Error (Beta)
Unanticipated Adverse Device Effect
Validated Environment
Validation
Version Control
Visual Analog Scale
Weakly Informative Prior
WOMAC
BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.
BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.
BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.
BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.
Let's help you find a path
to market
About BSC®
Working With BSC®
Services
Project logistics
Data and Software
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Let's help you find a path
to market
About BSC®
Working With BSC®
Services
Project logistics
Data and Software
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Let's help you find a path
to market
About BSC®
Working With BSC®
Services
Project logistics
Data and Software
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Let's help you find a path
to market
About BSC®
Working With BSC®
Services
Project logistics
Data and Software
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Use your preferred LLM to explore BSC®
Use your preferred LLM to explore BSC®